Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Drug-induced myopathies.

Z Argov1

  • 1Department of Neurology, Hadassah University Hospital and the Hebrew University-Hadassah Medical School, Jerusalem, Israel. zargov@md2.huji.ac.il

Current Opinion in Neurology
|November 10, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

EAN 2024 Guideline on the Diagnostic Approach to Oligo/Asymptomatic HyperCKemia.

European journal of neurology·2026
Same author

Statins and the neuromuscular system: a neurologist's perspective.

European journal of neurology·2014
Same author

EFNS/ENS Guidelines for the treatment of ocular myasthenia.

European journal of neurology·2014
Same author

Increased severity over generations of Charcot-Marie-Tooth disease type 1A.

Journal of neurology·2008
Same author

Dysferlinopathy in the Jews of the Caucasus: a frequent mutation in the dysferlin gene.

Neuromuscular disorders : NMD·2007
Same author

GNE protein expression and subcellular distribution are unaltered in HIBM.

Neurology·2007

This study examines controversial clinical myotoxicity, focusing on statin-induced myopathies and intensive care unit-acquired weakness. Further research is needed to clarify the unclear pathogenesis of these common muscle disorders.

Area of Science:

  • Clinical Neurology
  • Pharmacology
  • Intensive Care Medicine

Background:

  • Two significant clinical myotoxicity conditions remain controversial: statin-induced myopathies and acute quadriplegic myopathy in intensive care.
  • Both muscle disorders are prevalent, yet their underlying pathological mechanisms are not fully understood.

Purpose of the Study:

  • To present problematic issues surrounding cholesterol-lowering agent-induced myopathies and intensive care unit-acquired quadriplegic myopathy.
  • To suggest future research directions for clarifying the pathogenesis of these myopathies.

Main Methods:

  • Literature review and synthesis of existing research on clinical myotoxicity.
  • Identification and discussion of controversies and knowledge gaps in the pathogenesis of specific myopathies.

Related Experiment Videos

Main Results:

  • Highlights the controversial nature and unclear pathogenesis of statin-induced myopathies.
  • Discusses the challenges in understanding acute quadriplegic myopathy in intensive care settings.

Conclusions:

  • Emphasizes the need for further investigation into the mechanisms of these common myopathies.
  • Proposes specific research avenues to resolve current controversies and improve patient outcomes.